Interferon linked to COVID-19 severity.

Carvalho, Thiago

Carvalho, Thiago.

Carvalho T; , Lisbon, Portugal. h.stower@us.nature.com.

Nat Med ; 26(12): 1806, 2020 12.

Article in English | MEDLINE | ID: covidwho-963660

Subject(s)

Antibodies, Neutralizing/genetics; COVID-19/pathology; Interferon Type I/immunology; SARS-CoV-2/pathogenicity; Antibodies, Neutralizing/blood; COVID-19/epidemiology; COVID-19/genetics; COVID-19/immunology; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Interferon Type I/genetics; Interferon Type I/physiology; Pandemics; Primary Immunodeficiency Diseases/genetics; Primary Immunodeficiency Diseases/immunology; Primary Immunodeficiency Diseases/virology; Severity of Illness Index

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interferon Type I / Antibodies, Neutralizing / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2020 Document Type: Article Affiliation country: S41591-020-01164-x

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google